Expanded prenatal phenotype of ALG12-associated congenital disorder of glycosylation including bilateral multicystic kidneys

Am J Med Genet A. 2024 Sep;194(9):e63660. doi: 10.1002/ajmg.a.63660. Epub 2024 May 8.

Abstract

Congenital disorders of glycosylation (CDG) are a group of rare autosomal recessive genetic disorders caused by pathogenic variants in genes coding for N-glycosylated glycoproteins, which play a role in folding, degrading, and transport of glycoproteins in their pathway. ALG12-CDG specifically is caused by biallelic pathogenic variants in ALG12. Currently reported features of ALG12-CDG include: developmental delay, hypotonia, failure to thrive and/or short stature, brain anomalies, recurrent infections, hypogammaglobulinemia, coagulation abnormalities, and genitourinary abnormalities. In addition, skeletal abnormalities resembling a skeletal dysplasia including shortened long bones and talipes equinovarus have been seen in more severe neonatal presentation of this disorder. We report on a case expanding the phenotype of ALG12-CDG to include bilateral, multicystic kidneys in a neonatal demise identified with homozygous pathogenic variants in the ALG12 gene at c.1001del (p.N334Tfs*15) through clinical trio exome sequencing.

Keywords: ALG12; bilateral multicystic kidneys; congenital disorders of glycosylation.

Publication types

  • Case Reports

MeSH terms

  • Congenital Disorders of Glycosylation* / genetics
  • Congenital Disorders of Glycosylation* / pathology
  • Exome Sequencing
  • Female
  • Glycosylation
  • Humans
  • Mutation
  • Phenotype
  • Polycystic Kidney Diseases* / genetics
  • Polycystic Kidney Diseases* / pathology
  • Pregnancy
  • Stillbirth